Google has filed U.S. patent applications related to histamine biosynthesis production, with a focus on methods and systems for producing histamine. These applications detail processes that can be used to generate histamine, which is a biogenic amine with various physiological roles [1].
How is Histamine Produced in These Patents?
The patent applications describe methods involving engineered microorganisms. These microorganisms are genetically modified to enhance the production of histamine through metabolic engineering. Key steps often involve introducing or optimizing genes responsible for the enzymatic conversion of histidine to histamine, a process catalyzed by histidine decarboxylase [1].
What Are the Potential Applications of This Technology?
The technology described in Google's patent applications could have applications in several areas. Histamine is used in research as a biochemical tool, and it also has therapeutic potential in certain medical conditions. Furthermore, understanding and controlling biogenic amine production can be relevant in food science and biotechnology [1].
When Does Patent Protection Typically End?
For granted U.S. patents, the standard term of protection is 20 years from the filing date of the earliest application for that patent [2]. However, patent terms can be extended under certain circumstances, such as for regulatory delays [3]. DrugPatentWatch.com provides resources for tracking patent expirations for pharmaceuticals and related technologies [4].
Who Else is Working on Histamine Production Technology?
While specific competitors in the exact same niche as Google's patent applications are not detailed in the provided information, research and development in biogenic amine production and metabolic engineering is a broad field. Various academic institutions and biotechnology companies are engaged in similar work, aiming to produce valuable biomolecules using engineered organisms [1, 4].
What Are the Regulatory Considerations for Histamine Production?
The regulatory landscape for histamine production depends on its intended use. If produced for pharmaceutical applications, it would fall under the purview of regulatory bodies like the U.S. Food and Drug Administration (FDA). If used in other industrial or research contexts, different regulations might apply [1].
Where Can I Find More Information on Drug Patents and Exclusivity?
For comprehensive information on drug patents, exclusivity periods, and related intellectual property matters, resources such as DrugPatentWatch.com are valuable. They offer databases and analytics on patent landscapes for various therapeutic areas [4].
Sources
1. [Google patent applications related to histamine biosynthesis production]
2. [U.S. Patent and Trademark Office - Patent Term]
3. [U.S. Patent and Trademark Office - Patent Term Adjustment]
4. [DrugPatentWatch.com]